Nov. 27, 2023 Price forecast | 2 weeks: -3.04% | 1 month: -5.66% | 3 months: -7.60%


MDXG stock forecast

Our latest prediction for Mimedx Group Inc's stock price was made on the Nov. 27, 2023 when the stock price was at 7.92$.

In the short term (2weeks), MDXG's stock price should underperform the market by -3.04%. During that period the price should oscillate between -9.85% and +2.74%.

In the medium term (3months), MDXG's stock price should underperform the market by -7.60%. During that period the price should oscillate between -31.61% and +1.76%.

Create a solid portfolio with MDXG

Add MDXG to your portfolio and optimize it!


About Mimedx Group Inc

mimedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. the company processes the human placental tissue utilizing its proprietary purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. mimedx has supplied more than two million allografts, through both direct and consignment shipments. for additional information, please visit www.mimedx.com.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.02$ per share.

The book value per share is 1.28$

Mimedx Group Inc website


Three months stock forecastNov. 27, 2023


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - 11M - 4M -0.02 - - 116M 1.28 - - -